HYPOTHESIS: The object of this study was to find out whether cerumen and otorrhea have any infectivity in the transmission of hepatitis B virus (HBV). BACKGROUND: The HBV infection is a worldwide health problem. It can be transmitted by infected blood or other body fluids through percutaneous or permucosal exposure. Recently, there have been some reports where cerumen can be a potential source of HBV transmission. METHODS: This study was performed on 30 chronic hepatitis B patients who tested positive in hepatitis B surface antigen (HBs Ag). Thirty cerumen and 5 otorrhea samples were analyzed. The cerumen and the serum were examined for (HBs Ag) and hepatitis B e antigen (HBe Ag) by using enzyme immunoassay systems. As for HBV DNA detection, quantitative polymerase chain reaction was performed on the serum, cerumen, and otorrhea. RESULTS: : Hepatitis B virus DNA was detected in the 20 samples of cerumen (66.7%) and all 5 otorrhea (100%) from 30 patients. The mean values of HBV DNA in cerumen and otorrhea were significantly lower than serum. Hepatitis B virus DNA and HBs Ag were detected with significantly higher rates in the cerumen of patients who are serum HBe Ag positive than negative. However, positive HBe Ag, which implies that it is associated with the increased risk of disease progression and infectivity, was not detected in any of cerumen samples. CONCLUSION: The cerumen and otorrhea of chronic hepatitis B patients have a low risk of infectivity.
HYPOTHESIS: The object of this study was to find out whether cerumen and otorrhea have any infectivity in the transmission of hepatitis B virus (HBV). BACKGROUND: The HBV infection is a worldwide health problem. It can be transmitted by infected blood or other body fluids through percutaneous or permucosal exposure. Recently, there have been some reports where cerumen can be a potential source of HBV transmission. METHODS: This study was performed on 30 chronic hepatitis Bpatients who tested positive in hepatitis B surface antigen (HBs Ag). Thirty cerumen and 5 otorrhea samples were analyzed. The cerumen and the serum were examined for (HBs Ag) and hepatitis B e antigen (HBe Ag) by using enzyme immunoassay systems. As for HBV DNA detection, quantitative polymerase chain reaction was performed on the serum, cerumen, and otorrhea. RESULTS: : Hepatitis B virus DNA was detected in the 20 samples of cerumen (66.7%) and all 5 otorrhea (100%) from 30 patients. The mean values of HBV DNA in cerumen and otorrhea were significantly lower than serum. Hepatitis B virus DNA and HBs Ag were detected with significantly higher rates in the cerumen of patients who are serum HBe Ag positive than negative. However, positive HBe Ag, which implies that it is associated with the increased risk of disease progression and infectivity, was not detected in any of cerumen samples. CONCLUSION: The cerumen and otorrhea of chronic hepatitis Bpatients have a low risk of infectivity.
Authors: E Gholami Parizad; A Khosravi; E Gholami Parizad; K Sayehmiri; R Ranjbar Journal: Iran Red Crescent Med J Date: 2012-03-01 Impact factor: 0.611
Authors: E Gholami Parizad; A Khosravi; E Gholami Parizad; N Sadeghifard; S Ghafourian Journal: Iran J Public Health Date: 2012-02-29 Impact factor: 1.429
Authors: Yuce Islamoglu; Sami Bercin; Sibel Aydogan; Alp Sener; Fatih Tanriverdi; Gul Pamukcu Gunaydin; Bedia Dinc Journal: Ear Nose Throat J Date: 2020-10-15 Impact factor: 1.697